The physiology of a local renin-angiotensin system in the pancreas

Journal of Physiology

Volumn 580, Issue 1, 2007, Pages 31-37

  Leung, Po Sing ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 1B RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSINOGEN; BICARBONATE; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; INSULIN; IRBESARTAN; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; PERINDOPRIL; RAMIPRIL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RENIN; SOMATOSTATIN; TRANSFORMING GROWTH FACTOR BETA; UNCOUPLING PROTEIN 2; ANGIOTENSIN RECEPTOR; LOSARTAN;

ACINAR CELL; APOPTOSIS; AUTOCRINE EFFECT; BLOOD PRESSURE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL TRIAL; CYSTIC FIBROSIS; DIABETES MELLITUS; DRUG MECHANISM; DRUG TARGETING; ELECTROLYTE BALANCE; ENDOCRINE FUNCTION; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME RELEASE; FIBROSIS; FLUID BALANCE; GENE TARGETING; HUMAN; INFLAMMATION; INSULIN RELEASE; INSULIN SYNTHESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS; PANCREAS CANCER; PANCREAS DUCT; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PANCREAS ISLET DELTA CELL; PANCREATITIS; PARACRINE SIGNALING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; STELLATE CELL; ACUTE PANCREATITIS; DISEASE ASSOCIATION; DRUG EFFECT; GLUCOSE HOMEOSTASIS; HORMONAL REGULATION; HYPERGLYCEMIA; HYPOXIA; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PROTEIN EXPRESSION;

ANIMALS; HUMANS; ISLETS OF LANGERHANS; PANCREAS; PANCREAS, EXOCRINE; RENIN-ANGIOTENSIN SYSTEM;

EID: 33947526470     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.126193     Document Type: Review

References (49)

1. Abuissa H, Jones PG, Marso SP & O'Keefe JH (2005). Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes. J Am Coll Cardiol 46, 821-826.
2. Carlsson PO, Berne C & Jansson L (1998). Angitoensin II and the endocrine pancreas: Effects on islet blood flow and insulin secretion in rats. Diabetologia 41, 127-133.
3. Chan HC, Law SH, Leung PS & Wong PYD (1997). Angiotensin II receptor type I-regulated anion secretion in cystic fibrosis pancreatic duct cells. J Memb Biol 156, 241-250.
4. Chan WP, Fung ML, Nobiling R & Leung PS (2000). Activation of local renin-angiotensin system by chronic hypoxia in rat pancreas. Mol Cell Endocrinol 160, 107-114.
5. Chan YC & Leung PS (2006). AT1 receptor antagonism ameliorates acute pancreatitis-associated pulmonary injury. Regul Pept 134, 46-53.
6. Chappell MC, Diz DI & Jacobsen DW (1992). Pharmacological characterization of angiotensin II binding sites in the canine pancreas. Peptides 13, 311-318.
7. Chappell MC, Jacobsen DW & Tallant EA (1995). Characterization of angiotensin II receptor subtypes in pancreatic acinar AR42J cells. Peptides 16, 741-747.
8. Chappell MC, Milsted A, Diz DI, Brosnihan KB & Ferrario CM (1991). Evidence for an intrinsic angiotensin system in the canine pancreas. J Hypertens 9, 751-759.
9. Cheng HS, So SC, Law SH & Chan HC (1999). Angiotensin II-mediated signal transduction in cystic fibrosis pancreatic cells. Biochem Biophysica Acta 1449, 254-260.
10. 1A angiotensin receptor in pancreatoma AR4-2J cells. Peptides 20, 829-836.
11. Chu KY, Lau T, Carlsson PO & Leung PS (2006). Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes 55, 367-374.
12. Chu KY & Leung PS (2007). Angiotensin II type 1 receptor antagonism mediates uncoupling protein 2-driven oxidative stress and ameliorates pancreatic islet β-cell function in young type 2 diabetic mice. Antioxid Redox Signal in press.
13. De Gasparo M, Catt KJ, Inagami T, Wright JW & Unger T (2000). International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52, 415-472.
14. Lupi R, Del Guerra S, Bugliani M, Boggi U, Mosca F, Torri S, Del Prato S & Marchetti P (2006). The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets. Eur J Endocrinol 154, 355-361.
15. Fink AS, Wang Y, Mendez T, Worrell RT, Eaton D, Nguyen TD & Lee SP (2002). Angiotensin II evokes calcium-mediated signaling events in isolated dog pancreatic epithelial cells. Pancreas 25, 290-295.
16. Ghiani BU & Masini MA (1995). Angiotensin II binding sites in the rat pancreas and their modulation after sodium loading and depletion. Comp Biochem Physiol A Physiol 111, 439-444.
17. Howard-McNatt M & Fink AS (2002). Captopril inhibits secretin-induced pancreatic bicarbonate output. J Surg Res 103, 96-99.
18. Huang Z, Jansson L & Sjoholm A (2006). Pancreatic islet blood flow is selectively enhanced by captopril, irbesartan and pravastatin, and suppressed by palmitate. Biochem Biophys Res Comm 346, 26-32.
19. Huang Z, Jansson L & Sjoholm A (2007). Vasoactive drugs enhance pancreatic islet blood flow, augment insulin secretion and improve glucose tolerance in female rats. Clin Sci 112, 69-76.
20. Ip SP, Tsang SW, Wong TP, Che CT & Leung PS (2003 a). Saralasin, a non-specific angiotensin II receptor antagonist, attenuates oxidative stress and tissue injury in cerulien-induced acute pancreatitis. Pancreas 26, 224-229.
21. Ip SP, Wong TP, Tsai SJ & Leung PS (2003 b). The recovery of some components of the renin-angiotensin system in the rat pancreas after chronic exposure to hypoxic condition. J Mol Endocrinol 31, 563-571.
22. Kamp C, Lau T, Olsson R, Leung PS & Carlsson PO (2005). Angiotensin II type 1 receptor inhibition markedly improves the blood perfusion, oxygen tension and first phase of glucose-stimulated insulin secretion in revascularised syngeneic mouse islet grafts. Diabetologia 48, 1159-1167.
23. Ko SH, Hong OK, Kim JW, Ahn YB, Song KH, Cha BY, Son HY, Kim MJ, Jeong IK & Yoon KH (2006). High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system. J Cell Biochem 98, 343-355.
24. Ko SH, Kwon HS, Kim SR, Moon SD, Ahn YB, Song KH, Son HS, Cha BY, Lee KW, Son HY, Kang SK, Park CG, Lee IK & Yoon KH (2004). Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats. Biochem Biophys Res Commum 316, 114-122.
25. Kuno A, Yamada T, Kasuda K, Ogawa K, Sogawa M, Nakamura S, Ohara H, Nomura T, Joh T, Shirai T & Itoh M (2003). Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats. Gastroenterology 124, 1010-1010.
26. Kuwahira I, Gonzalez NC, Heisler N & Piipet J (1993). Changes in regional blood flow distribution and oxygen supply during hypoxia in conscious rats. J Appl Physiol 74, 211-214.
27. Lam KY & Leung PS (2002). Regulation and expression of renin-angiotensin system in human pancreas and pancreatic endocrine tumours. Eur J Endocrinol 146, 567-572.
28. Lau T, Carlsson PO & Leung PS (2004). Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 47, 240-248.
29. Lavoie JL & Sigmund CD (2003). Overview of the renin-angiotensin system: An endocrine and paracrine system. Endocrinology 144, 2179-2183.
30. Leung PS (2004). The peptide hormone angiotensin II: Its new functions in tissues and organs. Curr Protein Pept Sci 5, 267-273.
31. 2 in the pancreas of rodents. J Endocrinol 153, 269-274.
32. Leung PS, Chan WP & Nobiling R (2000). Regulated expression of pancreatic renin-angiotensin system in experimental pancreatitis. Mol Cell Endocrinol 166, 121-128.
33. Leung PS, Chan HC & Wong PYD (1998). Immunohistochemical localization of angiotensin II in the mouse pancreas. Histochem J 30, 21-25.
34. Leung PS, Chan WP, Wong TP & Sernia C (1999). Expression and localization of the renin-angiotensin system in the rat pancreas. J Endocrinol 160, 13-19.
35. Matsusaka T & Ichikawa I (1997). Biological functions of angiotensin and its receptors. Ann Rev Physiol 59, 395-412.
36. Montgomery H, Humphries SE & Leung PS (2003). Renin-angiotensin system: The new frontier. Int J Biochem Cell Biol 35, 758.
37. Nakayama M, Inoguchi T, Sonta T, Maeda Y, Sasaki S, Sawada F, Tsubouchi H, Sonoda N, Kobayashi K, Sumimoto H & Nawata H (2005). Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonist. Biochem Biophys Res Commun 332, 927-933.
38. Paul M, Mehr AP & Kreutz R (2006). Physiology of local renin-angiotensin systems. Physiol Rev 86, 747-803.
39. Peach M (1977). Renin-angiotensin system: Biochemistry and mechanism of action. Physiol Rev 57, 313-370.
40. Ramracheya RD, Muller DS, Wu Y, Whitehouse BJ, Huang GC, Amiel SA, Karalliedde J, Viberti G, Jones PM & Persaud SJ (2006). Direct regulation of insulin secretion by angiotensin II in human islets of Langerhans. Diabetologia 49, 321-331.
41. Reddy MK, Baskaran K & Moiteni A (1995). Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells. Proc Soc Exp Biol Medical 210, 221-226.
42. Shao J, Iwashita N, Ikeda F, Ogihara T, Uchida T, Shimizu T, Uchino H, Hirose T, Kawamori R & Watada H (2006). Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db/db mice. Biochem Biophys Res Commun 344, 1224-1233.
43. Tahmasebi M, Puddefoot JR, Inwang ER & Vinsion GP (1999). The tissue renin-angiotensin system in human pancreas. J Endocrinol 161, 317-322.
44. Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC & Cooper ME (2004). Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat. Diabetes 53, 989-997.
45. Tsang SW, Cheng CHK & Leung PS (2004 a). The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis. Regul Pept 119, 213-219.
46. 2 receptor antagonists and their effects on changes in the severity of pancreatitis. Int J Biochem Cell Biol 36, 330-339.
47. Tsang SW, Ip SP, Wong TP, Che CT & Leung PS (2003). Differential effects of saralasin and ramiprilat, the inhibitors of renin-angiotensin system, on cerulein-induced acute pancreatitis. Regul Pept 111, 47-53.
48. Wang XP, Zhang R, Wu K, Wu L & Dong Y (2004). Angiotensin II mediates acinar cell apoptosis during the development of rat pancreatic fibrosis by AT1R. Pancreas 29, 264-270.
49. Wong PF, Lee SS & Cheung WT (2004). Immunohistochemical colocalization of type II angiotensin receptors with somatostatin in rat pancreas. Regul Pept 117, 195-205.